Inactief instrument

Andere talen Pharmacyte Biotech Inc Other OTC

Aandelen

US67090R1005

slotkoers Other OTC Andere beurzen
- ^USD	-

18/03	PharmaCyte Biotech, Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 januari 2024	CI
2023	PharmaCyte Biotech, Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 oktober 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PharmaCyte Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	18/03
PharmaCyte Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	15/12
Femasys Inc. announced that it has received $6.85 million in funding from PharmaCyte Biotech, Inc. and other investors	22/11
Femasys Inc. announces tranche update	17/11
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.	16/11
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	15/11
Femasys Inc. announced that it expects to receive $6.85 million in funding from PharmaCyte Biotech, Inc.	14/11
PharmaCyte Biotech : Change in Certifying Accountants - Form 8-K	10/11
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	31-10-23
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology	31-10-23
PharmaCyte Biotech, Inc. Provides Corporate Update on Cell-In-A-Box Technology	31-10-23
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	18-09-23
PharmaCyte Biotech, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	18-09-23
PharmaCyte Biotech : Certificate of Incorporation/Bylaws - Form 8-K	07-09-23
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on February 2, 2023.	31-07-23
PharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	31-07-23
Tranche Update on PharmaCyte Biotech, Inc.'s Equity Buyback Plan announced on May 11, 2023.	15-06-23
PharmaCyte Biotech Announces Final Results of Tender Offer	15-06-23
PharmaCyte Biotech, Inc.'s Equity Buyback announced on May 11, 2023, has closed with 8,085,879 shares, representing 48.15% for $26.46 million.	09-06-23
PHARMACYTE BIOTECH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	11-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Pharmacyte Biotech Inc Other OTC

Aandelen

US67090R1005

Andere talen

Filters